Physician profile
Julia Rosner
NPI 1639706997
$1,493.15
in general payments reported to CMS, 2019-2025
15 companies · $613 in 2025
The $613 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $270 · 2024: $610 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.62 |
| Education | $237.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $343.27 | 2025 | Assure Wcd |
| Abbott Laboratories | $237.53 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $219.74 | 2024 | Xarelto |
| Siemens Medical Solutions USA, INC. | $177.20 | 2024 | Naeotom Alpha, Artis Icono Floor |
| Amgen INC. | $119.40 | 2025 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $119.23 | 2024 | |
| Atricure, INC. | $78.04 | 2024 | |
| Boston Scientific Corporation | $49.65 | 2025 | General - Therapies |
| Merck Sharp & Dohme LLC | $33.62 | 2024-2025 | Verquvo, Capvaxive |
| Abiomed | $32.27 | 2025 | |
| Lilly USA, LLC | $18.61 | 2025 | Zepbound, Mounjaro |
| Pfizer INC. | $17.24 | 2025 | |
| Philips North America LLC | $16.54 | 2023 | (5044) Mcot |
| Regeneron Healthcare Solutions, INC. | $16.29 | 2023 | Evkeeza |
| Medtronic, INC. | $14.52 | 2025 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Rosner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.